Ipilimumab administered to metastatic melanoma patients who progressed after dendritic cell vaccination

Background: Ipilimumab has proven to be effective in metastatic melanoma patients. The purpose of this study was to determine the efficacy of ipilimumab in advanced melanoma patients who showed progressive disease upon experimental dendritic cell (DC) vaccination. Methods: Retrospective analysis of...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncoimmunology
Main Authors: Boudewijns, Steve, Koornstra, Rutger H. T., Westdorp, Harm, Schreibelt, Gerty, van den Eertwegh, Alfons J. M., Geukes Foppen, Marnix H., Haanen, John B., de Vries, I. Jolanda M., Figdor, Carl G., Bol, Kalijn F., Gerritsen, Winald R.
Formato: Artigo
Idioma:Inglês
Publicado em: Taylor & Francis 2016
Assuntos:
Original Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5007966/
https://ncbi.nlm.nih.gov/pubmed/27622070
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/2162402X.2016.1201625
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados